Gtf. Schwenger et al., Nuclear factor of activated T cells and YY1 combine to repress IL-5 expression in a human T-cell line, J ALLERG CL, 104(4), 1999, pp. 820-827
Background: IL-5 is an inducible T-cell cytokine with the unique ability to
induce eosinophilia without increases in other cell compartments. Regulati
on of IL-5 expression is controlled primarily at the level of transcription
. The role of eosinophilia in allergic disorders indicates IL-5 as a target
for therapy.
Objective: This report aims to increase our understanding of IL-5 gene regu
lation by identifying distal control elements in the human (h) IL-5 promote
r, determining the transcription factors that bind these elements and eluci
dating their role in control of hIL-5 gene expression, Methods:
Methods used in this study include deoxyribonuclease I footprint analysis,
electrophoretic mobility shift assay, and functional analysis by transfecti
on of PER-117 cells with site-directed mutants of the hIL-5 promoter.
Results: We have identified a protected region in the distal hIL-5 promoter
that has sequence homology to the previously identified negative regulator
y element within BR3, This protected region has not been previously reporte
d and is shown to contain overlapping binding sites for YY1 and nuclear fac
tor of activated cells. The binding sites exist between positions -447 and
-459, and this sequence was named hPRE2-IL5, Substitution mutations that ab
olish binding of these proteins to hPRE2-IL5 result in a 2- to 3-fold incre
ase in hIL-5 promoter activity in activated human T cells.
Conclusion: We report the novel combination of YY1 and nuclear factor of ac
tivated T cells transcription factors binding to a distal hIL-5 promoter el
ement where both factors are involved in down-regulation of hIL-5 gene expr
ession in human T cell.